BridgeMD
New treatment option for Intracerebral Hemorrhage
Official title Precision Use of TXA in Intracerebral Hemorrhage
ClinicalTrials.gov ID: NCT07365150
What this study is testing
What is Tranexamic Acid (IV)?
Tranexamic Acid (IV) is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for intracerebral hemorrhage.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Primary Intracerebral hemorrhage (ICH) is a severe and disabling disease. The hematoma will expand within the first few hours, which contributes to increasing brain injury and worsening neurological prognosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Primary ICH Diagnosis
- Age ≥ 18 years
- Within 6 hours of ICH
- Supratentorial ICH
- GCS ≥8
You likely can't join if
- Severe pre-morbid disability (Pre-morbid modified Rankin scale 5)
- Anticipated surgical treatment
- Recent acute atherosclerotic cardiovascular diseases (e.g. acute coronary syndrome, ischemic stroke)
- Receiving anticoagulation
- Recent intravascular stent placement and on dual antiplatelet treatment
- Expected life expectancy of \<1 year
See the full eligibility criteria
- Primary ICH Diagnosis
- Age ≥ 18 years
- Within 6 hours of ICH
- Supratentorial ICH
- GCS ≥8
- Location-specific volume criteria (\>7ml for thalamus or internal capsule; \>30ml for putamen or lobar)
- Severe pre-morbid disability (Pre-morbid modified Rankin scale 5)
- Anticipated surgical treatment
- Recent acute atherosclerotic cardiovascular diseases (e.g. acute coronary syndrome, ischemic stroke)
- Receiving anticoagulation
- Recent intravascular stent placement and on dual antiplatelet treatment
- Expected life expectancy of \<1 year
- Inability to participate in follow-up activity
- Bleeding tendency
- Severe renal impairment
- Severe liver impairment
- Known contraindication or allergy to tranexamic acid
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.